RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/22160574http://www.w3.org/2000/01/rdf-schema#comment"The transmembrane transport of anticancer drugs is mainly regulated by P-glycoprotein encoded by the human multidrug resistance gene 1 gene (MDR1). Since there were controversies regarding the association between MDR1 C3435T polymorphism and response to chemotherapy among patients with advanced breast cancer, a meta-analysis of the link was conducted. A total of 7 studies consist of 464 advanced breast cancer patients relating MDR1 C3435T polymorphism to the response of chemotherapy were included in this meta-analysis. The main analysis revealed a lack of association between the MDR1 C3435T and response to chemotherapy, with odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) of 1.37 (95% CI: 0.78-2.40), 1.17 (95% CI: 0.69-2.01), 1.18 (95% CI: 0.76-1.84) and 1.61 (95% CI: 0.70-3.68) for homozygous comparison, heterozygous comparison, dominant model and recessive model, respectively. The subgroup analysis by ethnicity did not change the pattern of results, with ORs of 0.99 (95% CI: 0.11-9.07), 0.68 (95% CI: 0.29-1.60), 0.81 (95% CI: 0.36-1.85) and 1.51 (95% CI: 0.77-2.96), in homozygous comparison, heterozygous comparison, dominant model and recessive model, respectively in Caucasian, and 1.50 (95% CI: 0.75-3.03), 1.72 (95% CI: 0.85-3.47), 1.59 (95% CI: 0.90-2.80) and 2.29 (95% CI: 0.51-10.35), respectively in Asian. The available evidence indicates that MDR1 C3435T polymorphism cannot be considered as a reliable predictor of response to chemotherapy in patients with advanced breast cancer."xsd:string
http://purl.uniprot.org/citations/22160574http://purl.org/dc/terms/identifier"doi:10.1007/s11033-011-1312-2"xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/author"Chen G."xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/author"Hu Q."xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/author"Quan S."xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/author"Wu J."xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/author"Wang L."xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/author"Xia X."xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/name"Mol Biol Rep"xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/pages"5161-5168"xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/title"Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studies."xsd:string
http://purl.uniprot.org/citations/22160574http://purl.uniprot.org/core/volume"39"xsd:string
http://purl.uniprot.org/citations/22160574http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/22160574
http://purl.uniprot.org/citations/22160574http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/22160574
http://purl.uniprot.org/uniprot/#_F4ZUY5-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574
http://purl.uniprot.org/uniprot/#_A1L471-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574
http://purl.uniprot.org/uniprot/#_A4D1D2-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574
http://purl.uniprot.org/uniprot/#_A8E2S6-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574
http://purl.uniprot.org/uniprot/#_B5U2G4-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574
http://purl.uniprot.org/uniprot/#_F4ZUQ5-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574
http://purl.uniprot.org/uniprot/#_F4ZUT2-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574
http://purl.uniprot.org/uniprot/#_F4ZUV0-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574
http://purl.uniprot.org/uniprot/#_F4ZUV4-mappedCitation-22160574http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22160574